Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Lancet Neurol. 2018 Feb 1;17(3):241–250. doi: 10.1016/S1474-4422(18)30028-0

Table 1.

Study demographics at baseline.

Demographics at Baseline
Non-Carriers Asymptomatic Carriers Symptomatic Carriers
Number 148 141 88
Females (%) 85 (57%) 78 (55%) 49 (56%)
Age (years/sd) 39·5 (11·4) 34·6 (9·2) 45·7 (9·9)
MMSE (mean/sd) 29·0 (2·7) 28·8 (2·7) 23·9 (10·2)
CDR-SOB (mean/SD) 0·0 (0·2) 0·0 (0·1) 3·6 (3·5)
EYO (years/sd) −8·9 (11·4) −13·7 (9·2) 0·5 (7·1)
PSEN1/PSEN2/APP 122/17/9 (82/11/6%) 117/16/8 (83/11/6%) 76/6/6 (86/7/7%)
N with Follow up (%) 70 (47%) 73 (52%) 58 (66%)
 N of visits*(sd) 2·3 (0·8) 2·3 (0·8) 2·8 (1·2)
 Follow up in years* (sd) 3·0 (1·7) 3·0 (1·6) 2·0 (1·3)

Summary of Imaging Data

Data By Modality PIB FDG MRI
1 visit 184 177 176
2 visits 124 131 145
3 visits 23 27 35
4 visits 10 11 11
5 visits 4 5 8
6 visits 1 1 2
Total Subjects 346 352 377
*

Summary values are only for those individuals with longitudinal data

EYO - estimated years to dementia onset

MMSE – Mini Mental State Examination

CDR-SOB – Clinical Dementia Rating Sum of Boxes